Decrease of preexisting antibodies after <i>P</i>. <i>yoelii</i> infection. by Simran Banga (227952)

miR-132 Knockdown Decreases Dendritic Spine Density <i>In Vivo</i>. by Bryan W. Luikart (351588)

Immunization Using GroEL Decreases <i>Clostridium difficile</i> Intestinal Colonization by Séverine Péchiné (490094)

Image_5_Age-Dependent Decrease in the Induction of Regulatory T Cells Is Associated With Decreased Expression of RALDH2 in Mesenteric Lymph Node Dendritic Cells.TIF by Tomohiro Takano (9227690)

“…As factors, we found that the proportion of the CD11b^–CD103⁺PD-L1^high subset was decreased in aged mice compared with that in young mice and that RALDH enzyme activity was decreased in the CD11b^–CD103⁺PD-L1^high and CD11b⁺CD103⁺PD-L1^high subsets. …”

Image_3_Age-Dependent Decrease in the Induction of Regulatory T Cells Is Associated With Decreased Expression of RALDH2 in Mesenteric Lymph Node Dendritic Cells.tif by Tomohiro Takano (9227690)

“…As factors, we found that the proportion of the CD11b^–CD103⁺PD-L1^high subset was decreased in aged mice compared with that in young mice and that RALDH enzyme activity was decreased in the CD11b^–CD103⁺PD-L1^high and CD11b⁺CD103⁺PD-L1^high subsets. …”

Image_6_Age-Dependent Decrease in the Induction of Regulatory T Cells Is Associated With Decreased Expression of RALDH2 in Mesenteric Lymph Node Dendritic Cells.TIF by Tomohiro Takano (9227690)

“…As factors, we found that the proportion of the CD11b^–CD103⁺PD-L1^high subset was decreased in aged mice compared with that in young mice and that RALDH enzyme activity was decreased in the CD11b^–CD103⁺PD-L1^high and CD11b⁺CD103⁺PD-L1^high subsets. …”

Image_2_Age-Dependent Decrease in the Induction of Regulatory T Cells Is Associated With Decreased Expression of RALDH2 in Mesenteric Lymph Node Dendritic Cells.TIF by Tomohiro Takano (9227690)

“…As factors, we found that the proportion of the CD11b^–CD103⁺PD-L1^high subset was decreased in aged mice compared with that in young mice and that RALDH enzyme activity was decreased in the CD11b^–CD103⁺PD-L1^high and CD11b⁺CD103⁺PD-L1^high subsets. …”

Image_4_Age-Dependent Decrease in the Induction of Regulatory T Cells Is Associated With Decreased Expression of RALDH2 in Mesenteric Lymph Node Dendritic Cells.tif by Tomohiro Takano (9227690)

“…As factors, we found that the proportion of the CD11b^–CD103⁺PD-L1^high subset was decreased in aged mice compared with that in young mice and that RALDH enzyme activity was decreased in the CD11b^–CD103⁺PD-L1^high and CD11b⁺CD103⁺PD-L1^high subsets. …”

HR plots of % PCT decrease for survival (A) and recovery from dialysis (B) in predefined subgroups. by Il Young Kim (10757390)

<b>Nest mass in forest tits </b><b><i>Paridae</i></b><b> </b><b>increases with elevation and decreasing body mass, promoting reproductive success</b> by Clara Wild (19246606)

Glucose inhibition decreases IL-1β levels and tumor progression in the B16F10 mouse model. by Yunseo Woo (6157307)

JARID1B downregulation results in the decrease of cell invasion capability. by Yung-Ting Kuo (736349)

Image_1_Rodent Models of Spondyloarthritis Have Decreased White and Bone Marrow Adipose Tissue Depots.jpg by Giulia Furesi (10909305)

NTM cells treated with TGFβ1 show increased expression of COL1A1 and DNMT1 and decreased expression of RASAL1. by Fiona McDonnell (2636635)

“…<b>B.</b> Upon investigation of mRNA expression of COL1A1, DNMT1 and RASAL1 by qPCR, we found that COL1A1 (P<0.05) and DNMT1 were increased and RASAL1 (P<0.05) was decreased in the cells treated with TGFβ1. …”

The amount of plasmid DNA associated with Ssb-GFP was decreased in the plasmid with <i>sso1</i>. by Laurel D. Wright (803708)

Silencing JARID1B decreases epithelial to mesenchymal transition (EMT). by Yung-Ting Kuo (736349)

GO treatment decreased SR-B1 levels. by Claudia Sticozzi (329024)

Rab27A deficiency caused decreased amylase release from isolated acini. by Yanan Hou (736195)

B-THP-Ts decrease cellular ATP levels. by Lindsay B. Tulloch (1266861)

Subjects:

miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression by Florian Kopp (115988)

“…Moreover, the receptor tyrosine kinase TrkB and the transcriptional repressor Bmi1 were identified as miR-200c targets mediating the drug resistance. …”